Skip to content
StockMarketAgent
Sector pending / Medicinal Chemicals and Botanical ProductsUpdated 2026-05-10 22:07 UTC

BOM/540737 stock hub

BOM/540737 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BOM/540737is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
6.8B
Bombay Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BOM/540737
In the news

Latest news · BOM/540737

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E37.7
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC11.8
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BOM/540737 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
175
Groups with data
10
Currency
INR
Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
India
Country code
IN
Employees
149
Employees Change
10%
Employees Change Percent
7.19
Enterprise value
INR 6.9B
Exchange
Bombay Stock Exchange
Financial currency
INR
First seen
2026-05-10
Industry
Medicinal Chemicals and Botanical Products
Last refreshed
2026-05-10
Market cap
INR 6.8B
Price
INR 531
Price currency
INR
Rev Per Employee
6,746,409.4x
Sic
2833
Symbol
bom/540737
Website
https://www.ganeshremedies.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
2.65%
EV Earnings
37.88x
EV/EBIT
27.82x
EV/EBITDA
18.6x
EV/Sales
6.81x
P/B ratio
4.44x
P/E ratio
37.68x
P/S ratio
6.78x
PE Ratio10 Y
22.84x
PE Ratio3 Y
32.29x
PE Ratio5 Y
30.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
24.49%
EBITDA Margin
36.15%
Gross margin
63.43%
Gross Profit
INR 637.6M
Gross Profit Growth
-18.34%
Gross Profit Growth Q
-20.8%
Gross Profit Growth3 Y
18.53%
Gross Profit Growth5 Y
19.97%
Net Income
INR 180.8M
Net Income Growth
-36.49%
Net Income Growth Q
-43.01%
Net Income Growth3 Y
6.44%
Net Income Growth5 Y
14.06%
Pretax Margin
23.94%
Profit Margin
17.99%
Profit Per Employee
INR 1.2M
Roa5y
12.49
Roe5y
22.34
ROIC
11.75
Roic5y
18.86

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr1y
-26.07%
Cagr3y
18.92%
Cagr5y
17.35%
Div CAGR3
0%
Div CAGR5
-19.27%
EPS Growth
-36.54
EPS Growth Q
-42.89
EPS Growth3 Y
4.08
EPS Growth5 Y
12.53
Revenue Growth
-17.57x
Revenue Growth Q
-21.98x
Revenue Growth3 Y
7.26x
Revenue Growth5 Y
15.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

13
MetricValue
Cash
INR 336.9M
Debt
INR 375.3M
Debt EBITDA
INR 1.02
Debt Equity
INR 0.24
Equity
INR 1.5B
Interest Coverage
6.92
Net Cash
INR -38.4M
Net Cash By Market Cap
INR -0.56
Net Debt EBITDA
INR 0.11
Net Debt Equity
INR 0.03
Tangible Book Value
INR 1.5B
Tangible Book Value Per Share
INR 119
WACC
6.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-0.09%
Dividend per share
INR 0
Last Dividend
INR 0.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-26.06%
200-day SMA
499.6
3Y total return
68.21%
50-day SMA
493.9
50-day SMA vs 200-day SMA
50under200
5Y total return
122.53%
All Time High
950.1
All Time High Change
-44.15%
All Time High Date
2024-07-26
All Time Low
22.23
All Time Low Change
2,287.19%
All Time Low Date
2017-10-13
ATR
28.62
Beta
0.36
Beta1y
0.49
Beta2y
0.47
Ch YTD
14.55
High
548.4
High52
794
High52 Date
2025-05-19
High52ch
-33.17%
Low
512
Low52
381.1
Low52 Date
2026-01-27
Low52ch
39.23%
Ma50ch
7.43%
Price vs 200-day SMA
6.21%
RSI
59.74
RSI Monthly
48.65
RSI Weekly
55.92
Sharpe ratio
-0.73x
Sortino ratio
-0.88
Total Return
-0.09%
Tr YTD
14.55
Tr1m
12.98%
Tr1w
8.91%
Tr3m
13.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
INR 246.2M
Operating Income Growth
-36.26
Operating Income Growth Q
-43.58
Operating Income Growth3 Y
13.16
Operating Income Growth5 Y
19.51
Operating margin
24.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
3,090,999%
Shares Insiders
75.92%
Shares Institutions
0%
Shares Out
12,837,620
Shares Qo Q
-0.1%
Shares Yo Y
0.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

48
MetricValue
Average Volume
3,712.65x
Bv Per Share
119.6
Ch1m
12.98
Ch1w
8.91
Ch1y
-26.06
Ch3m
13.85
Ch3y
68.02
Ch5y
119.2
Ch6m
8.49
Change
8.65%
Change From Open
-3.25
Close
488.4
Days Gap
12.3
Depreciation Amortization
117,189,500
Dollar Volume
4,985,517.6
Earnings Date
2026-05-21
EBIT
INR 246.2M
EBITDA
INR 363.4M
EPS
INR 14.08
F Score
1
Fiscal Year End
March
Founded
1,995
Graham Number
194.64453
Graham Upside
-63.32
Income Tax
INR 59.8M
Is Primary Listing
1
Last Earnings Date
2026-02-23
Last Report Date
2025-12-31
Last Split Date
2021-11-01
Last Split Type
Forward
Lynch Fair Value
INR 198
Lynch Upside
-62.68
Ma150
475.7
Ma150ch
11.54%
Ma20
504.7
Ma20ch
5.13%
Next Earnings Date
2026-05-21
Open
548.4
Position In Range
51.1
Price Date
2026-05-08
Price EBITDA
INR 18.75
Ptbv Ratio
4.45
Relative Volume
2.53x
Revenue
1,005,215,000x
Tax By Revenue
5.95x
Tax Rate
24.87%
Tr6m
8.49%
Volume
9,396
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BOM/540737 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/540737 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-26.1%
S&P 500 1Y: n/a
3Y total return
+68.2%
S&P 500 3Y: n/a
5Y total return
+122.5%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BOM/540737?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.0%
Share of float held by funds and institutions
Insider ownership
+75.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.1%
Negative means the company is buying back shares.
Technical

BOM/540737 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
59.7
Neutral momentum band
Price vs 200-day MA
+6.2%
50/200-day relationship not available
Beta (5Y)
0.36
Less volatile than the market
Sharpe ratio
-0.73
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BOM/540737

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/540737 stock rating?

bom/540737 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/540737 analysis?

The full report lives at /stocks/bom/540737/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/540737?

The latest report frames bom/540737 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/540737 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

bom/540737 stock profile: metrics, valuation and analysis | Agente de Mercado de Ações com IA